NanoViricides Inc. Submits Pre-IND Briefing Document for its Anti-Influenza drug, FluCide, to the US FDA
NanoViricides, Inc. announced today that it has submitted a pre-IND briefing document to the US FDA. This submission provides the required information for the Company's highly effective anti-influenza drug candidate, FluCide, in support of a pre-IND Meeting.
Posted: Jan 31st, 2012Read more